NEW YORK ( TheStreet) -- Shares of Synta Pharmaceuticals (Nasdaq: SNTA) were gapping up Wednesday morning with an open price 11.9% higher than Tuesday's closing price. The stock closed at $4.69 Tuesday and opened today's trading at $5.25. The average volume for Synta has been 185,600 shares per day over the past 30 days. Synta has a market cap of $186.5 million and is part of the health care sector and drugs industry. Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. TheStreet Ratings rates Synta as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. You can view the full Synta Ratings Report.